CIK 0001721484 · <br>Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472174146
- Phone
- 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | Agafonova Nataliya Chief Medical Officer | Grant or award | +175,750 | 177,521 | ||
| 2024-08-15 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −14,391 | $2.46 | $35K | 163,130 |
| 2024-08-15 | Agafonova Nataliya Chief Medical Officer | Grant or award · Stock Option (right to buy) | +16,250 | 16,250 | ||
| 2024-08-15 | Locklear Lisa Chief Financial Officer | Grant or award | +174,750 | 177,666 | ||
| 2024-08-15 | Locklear Lisa Chief Financial Officer | Shares withheld for taxes | −14,035 | $2.46 | $35K | 163,631 |
| 2024-08-15 | Locklear Lisa Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,250 | 16,250 | ||
| 2024-08-15 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Grant or award | +311,250 | 330,866 | ||
| 2024-08-15 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Shares withheld for taxes | −39,248 | $2.46 | $97K | 90,368 |
| 2024-08-15 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Grant or award · Stock Option (right to buy) | +28,750 | 28,750 | ||
| 2024-08-15 | Lehr Paul T General Counsel, Secretary | Grant or award | +178,133 | 320,214 | ||
| 2024-08-15 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −31,505 | $2.46 | $78K | 288,709 |
| 2024-08-15 | Lehr Paul T General Counsel, Secretary | Grant or award · Stock Option (right to buy) | +16,250 | 16,250 | ||
| 2024-08-15 | Hare Joshua Chief Scientific Officer | Grant or award | +93,766 | 727,046 | ||
| 2024-08-15 | Hare Joshua Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2024-08-15 | Baluch Khoso Director | Grant or award | +23,500 | 38,375 | ||
| 2024-08-15 | Ungaro Ursula Director | Grant or award | +23,500 | 24,000 | ||
| 2024-08-15 | Soffer Rock Director | Grant or award | +23,500 | 232,034 | ||
| 2024-08-15 | Hare Neil E Director | Grant or award | +23,500 | 29,352 | ||
| 2024-07-02 | Hajjar Roger Joseph Director | Grant or award | +16,000 | $1.68 | $27K | 16,000 |
| 2024-07-02 | Motwani Neha J. Director | Grant or award | +16,000 | $1.68 | $27K | 16,000 |
Page 6 of 7 · 123 trades